Reslizumab for treating severe eosinophilic asthma

Equality Impact Assessment (Guidance development) (PDF 234 KB)

Final appraisal determination: 2

Final appraisal determination document 2 (PDF 375 KB)

Final appraisal determination: 1

Public committee slides (PowerPoint 149 KB)

Final appraisal determination document (PDF 374 KB)

Committee papers (PDF 2.12 MB)

Draft guidance: 2

Appraisal consultation document (PDF 357 KB)

Committee papers (PDF 2.89 MB)

Committee papers Clinical and Cost effectiveness presentation slides (PDF 509 KB)

Draft guidance

Committee papers (PDF 9.36 MB)

Committee papers Clinical presentation slides (PDF 372 KB)

Committee papers Cost presentation slides  (PDF 333 KB)

Appraisal consultation document (PDF 364 KB)

Final scope (PDF 107 KB)

Final matrix (PDF 97 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 308 KB)

Equality impact assessment (Scoping) (PDF 120 KB)

Draft scope (pre-referral) (PDF 114 KB)

Provisional matrix (pre-referral) (PDF 98 KB)